Controlled trial observes minimal change in oxidative stress markers following topical doxycycline in periodontal disease, suggesting limited systemic antioxidant effects from local therapy.
The aim of this study is to determine the changes in the serum levels of malondialdehyde and 8-hydroxy-2'-deoxyguanosine, as indicators of oxidative stress, in response to periodontal treatment adyuvanted with topical doxycycline. Methods: Thirty four patients with periodontal disease were studied (DOX group n=16; Control group n=18), determining the serum levels of malondialdehyde and 8-hydroxy-2'-deoxyguanosine in urine at baseline and three months after non-surgical periodontal treatment. Results: We observed a slight trend to decrease in 8-OHdG urine levels after periodontal treatment, being this decrease greater in the DOX group (t1: 9.64 ± 7.18 μg/g; t0: 9.84 ± 3.01 μg/g) than in the control group (t1: 8.79 ± 4.08 μg/g; t0: 8.82 ± 4.01 μg/g). However, these changes were not statistically significant. No changes in serum levels of MDA were observed after periodontal treatment. BOP was positively correlated with 8-OHdG, in the DOX group (r = 0.563, p = 0.018). Conclusion: Periodontitis, as a local inflammatory disease, can cause an increase in oxidative stress, thus opening the way to new therapeutic strategies, while exploring novel strategies for modulating the host response.
No takes yet. Share an insight, caveat, or question.
Andreu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: